Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome

NAEnrolling by invitationINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 30, 2024

Primary Completion Date

October 30, 2024

Study Completion Date

December 31, 2024

Conditions
Chronic WoundMyofascial Pain Syndrome
Interventions
DRUG

HA35 injection

HA35/B-HA injection (Registration number L20200708MP07707; Ministry of Health). The subjects can continue to take oral analgesics during the treatment period, and the comparison of the dose and interval days of the analgesics before and after the treatment can also be used as the effect judgment of the injection.

Trial Locations (1)

Unknown

Nahia Impex Llc, Ulaanbaatar

All Listed Sponsors
lead

Nakhia Impex LLC

INDUSTRY